In 81.8% of primary HER2-positive breast cancer with bone metastases, pAKT levels were elevated, and the HER2/CXCR4/AKT pathway was suggested to play an important role in bone metastasis [58]. This evidence concerns the gene CXCR4 and breast carcinoma.